Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Troglitazone has a reducing effect on thromboxane production.

T Hishinuma1, T Yamazaki, M Mizugaki

  • 1Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, 980-8574, Sendai, Japan.

Prostaglandins & Other Lipid Mediators
|August 12, 2000
PubMed
Summary

Troglitazone, an antidiabetic drug, significantly reduced thromboxane production in human cells and platelets. This suggests thiazolidinediones may offer antithrombotic benefits, potentially preventing diabetes-related vascular complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

Effect of peroxisome proliferator-activated receptor gamma on thromboxane A(2) and prostaglandin E(2) production in macrophage cell lines.

Prostaglandins, leukotrienes, and essential fatty acids·2002
Same author

Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry.

Prostaglandins, leukotrienes, and essential fatty acids·2002
Same author

Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis.

Prostaglandins, leukotrienes, and essential fatty acids·2002
Same author

Expression of DNA methyltransferase (Dnmt1) in testicular germ cells during development of mouse embryo.

Cell structure and function·2002
Same author

Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications.

Prostaglandins, leukotrienes, and essential fatty acids·2001

Area of Science:

  • Pharmacology
  • Biochemistry
  • Endocrinology

Background:

  • Diabetes mellitus is associated with vascular complications.
  • Thromboxane (TX) plays a role in vascular health.
  • Troglitazone is an antidiabetic drug that improves insulin sensitivity.

Purpose of the Study:

  • To investigate the effects of troglitazone on thromboxane production.
  • To compare troglitazone with other compounds like alpha-tocopherol and BRL 49653.
  • To assess the antithrombotic potential of thiazolidinediones.

Main Methods:

  • Assessed TX production in human erythroleukemia (HEL) cells and human platelets.
  • Utilized gas chromatography/selected ion monitoring (GC/SIM) for TX measurement.
  • Administered arachidonic acid (AA) and thrombin to induce TX production/release.

Related Experiment Videos

Main Results:

  • Troglitazone significantly reduced basal and induced TX production in HEL cells and platelets.
  • The thiazolidinedione compound BRL 49653 demonstrated similar inhibitory effects.
  • Alpha-tocopherol showed no significant effect on TX production.

Conclusions:

  • The thiazolidinedione moiety confers an antithrombotic effect.
  • Troglitazone's inhibition of TX production may contribute to preventing vascular complications in diabetes.
  • Thiazolidinediones show promise as a therapeutic strategy for diabetic vascular disease.